Retraction
Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models
Paper Information
Record ID:
54059
Author(s):
Fariba Karoon Kiani
Sepideh Izadi
Ehsan Ansari Dezfouli
Farbod Ebrahimi
Mohammad Mohammadi
Hengameh Chalajour
Mirmohammad Mortazavi Bulus
Maryam Nasr Esfahani
Vahid Karpisheh
Armin Mahmoud Salehi Khesht
Kazem Abbaszadeh-Goudarzi
Ali Soleimani
Jamshid Gholizadeh Navashenaq
Majid Ahmadi
Hadi Hassannia
Mohammad Hojjat-Farsangi
Sima Shahmohammadi Farid
Vida Hashemi
Farhad Jadidi-Niaragh
Sepideh Izadi
Ehsan Ansari Dezfouli
Farbod Ebrahimi
Mohammad Mohammadi
Hengameh Chalajour
Mirmohammad Mortazavi Bulus
Maryam Nasr Esfahani
Vahid Karpisheh
Armin Mahmoud Salehi Khesht
Kazem Abbaszadeh-Goudarzi
Ali Soleimani
Jamshid Gholizadeh Navashenaq
Majid Ahmadi
Hadi Hassannia
Mohammad Hojjat-Farsangi
Sima Shahmohammadi Farid
Vida Hashemi
Farhad Jadidi-Niaragh
Journal:
Publication Date:
November 20, 2021
Retraction Date:
June 08, 2024
(1.4 year years ago)
Subjects:
Institutions:
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
- Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
- Nanoparticle Process Technology, Faculty of Engineering, University of Duisburg-Essen, Duisburg, Germany
- Department of Cell and Molecular Biology, School of Advanced Sciences, Islamic Azad University, Tehran, Medical Branch, Iran
- Department of Biochemistry, Faculty of Materials Engineering, Islamic Azad University, Najafabad Branch, Najafabad, Iran
- Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran
- Department of Public Health, Maragheh University of Medical Sciences, Maragheh, Iran
- Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran
- Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- Immunogenetic Research Center, Mazandaran University of Medical Sciences, Sari, Iran
- Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
- Department of Immunology, School of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
- Department of Basic Science, Faculty of Medicine, Maragheh University of Medical Sciences, Maragheh, Iran
- Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Countries:
Article Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.lfs.2024.122775Additional Notes:
see also: https://pubpeer.com/publications/D5350E55BBC742D8078062CDAA9964
Citations (22)
22
Total Citations7
Post-Retraction(31.8%)
15
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
7
Within 1 year
0
After 2+ years
345
Days since retraction (latest)
The progress and prospects of targeting the adenosine pathway in cancer immunotherapy
Yuying Yang, Lin Zhu, Yantao Xu et al. (8 authors)
Biomarker Research
Open Access
Published: May 2025
1 citation
1 citation
345 days after retraction
Metal nanoparticles as a promising therapeutic approach for prostate cancer diagnosis and therapy: a comprehensive review
Mohamed J. Saadh, Wajida Ataallah Khidr, Karar H. Alfarttoosi et al. (12 authors)
Medical Oncology
Published: Feb 2025
2 citations
2 citations
260 days after retraction
Biomaterials’ enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment
J. Paul Santerre, Yangyang Yang, Ziwei Du et al. (5 authors)
Frontiers in Immunology
Open Access
Published: Nov 2024
1 citation
1 citation
157 days after retraction
Administration of a combination of COX-2/TGF-β1 siRNAs induces hypertrophic scar fibroblast apoptosis through a TP53 mediated caspase pathway
Rao Fu, Sizheng Zhou, Chuanqi Liu et al. (5 authors)
Scientific Reports
Open Access
Published: Nov 2024
2 citations
2 citations
147 days after retraction
The potential of nanosystems in disrupting adenosine signaling pathways for tumor immunotherapy
Yutong Zhao, Jingqi Sun, Xiaoling Xu et al. (5 authors)
Expert Opinion on Drug Delivery
Published: Oct 2024
1 citation
1 citation
136 days after retraction
The advancement of siRNA-based nanomedicine for tumor therapy
Muchuan Qiao, Chenlu Zeng, Changqing Liu et al. (6 authors)
Nanomedicine
Published: Aug 2024
5 citations
5 citations
68 days after retraction
Unlocking the adenosine receptor mechanism of the tumour immune microenvironment
Yecheng Han, Chenshuang Dong, Mingwang Hu et al. (5 authors)
Frontiers in Immunology
Open Access
Published: Jun 2024
8 citations
8 citations
19 days after retraction
Molecular Engineering of Functional SiRNA Agents
Neelu Batra, Meijuan Tu, Ai‐Ming Yu
ACS Synthetic Biology
Open Access
Published: May 2024
2 citations
2 citations
28 days before retraction
Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade
Young‐Jin Choi, Su Hyun Seok, Hong Yeol Yoon et al. (5 authors)
Advanced Drug Delivery Reviews
Open Access
Published: Apr 2024
29 citations
29 citations
53 days before retraction
Theranostic Properties of Iron Oxide Nanoparticles and Their Reprograming Properties on Tumor-Associated Macrophages
Alexandre M. M. Dias, Alan Courteau, Camille Petitot et al. (13 authors)
Interdisciplinary cancer research
Published: Jan 2024
1 citation
1 citation
159 days before retraction
Nanoparticles targeting the adenosine pathway for cancer immunotherapy
Kehua Jiang, Jian Wu, Qing Wang et al. (7 authors)
Journal of Materials Chemistry B
Published: Jan 2024
4 citations
4 citations
159 days before retraction
Nanostructures-Based Polymeric Composite for Theranostic Applications
Poonam Jain, K. Gireesh Babu, Madhusudhan Alle et al. (4 authors)
Unknown Journal
Published: Jan 2024
159 days before retraction
Administration of a Combination of COX-2/TGF-β1 siRNAs Induces Hypertrophic Scar Fibroblast Apoptosis through a TP53 mediated Caspase Pathway
Rao Fu, Sizheng Zhou, Chuanqi Liu et al. (5 authors)
Research Square (Research Square)
Open Access
Published: Oct 2023
224 days before retraction
Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy
Songlin Liu, Haiyang Wang, Xinzhe Shao et al. (9 authors)
Journal of Nanobiotechnology
Open Access
Published: Jul 2023
15 citations
15 citations
340 days before retraction
A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages
Ying Bai, Xin Zhang, Jiawei Zhou et al. (10 authors)
Chemico-Biological Interactions
Open Access
Published: May 2023
11 citations
11 citations
374 days before retraction
IQGAP3 is relevant to prostate cancer: A detailed presentation of potential pathomechanisms
Wenjuan Mei, Ying Dong, Yan Gu et al. (8 authors)
Journal of Advanced Research
Open Access
Published: Jan 2023
6 citations
6 citations
507 days before retraction
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies
Michael Gabel, A. Knauss, Dagmar Fischer et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Nov 2022
6 citations
6 citations
575 days before retraction
Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia
Alexandre M. M. Dias, Alan Courteau, Pierre‐Simon Bellaye et al. (10 authors)
Pharmaceutics
Open Access
Published: Nov 2022
41 citations
41 citations
581 days before retraction
Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles
Abbas Ali Hosseinpour Feizi, Sajjad Vakili‐Samiani, Vahid Karpisheh et al. (14 authors)
Journal of Drug Delivery Science and Technology
Published: Oct 2022
9 citations
9 citations
602 days before retraction
RETRACTED ARTICLE: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model
Asal Barshidi, Vahid Karpisheh, Fatemeh Karimian Noukabadi et al. (17 authors)
Pharmaceutical Research
Published: Jun 2022
10 citations
10 citations
722 days before retraction
CD39 – A bright target for cancer immunotherapy
Shuwei Guo, Fengfeng Han, Wei Zhu
Biomedicine & Pharmacotherapy
Open Access
Published: May 2022
41 citations
41 citations
760 days before retraction
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades
Cheng‐Long Han, Yu‐Chuan Yan, Lun‐Jie Yan et al. (11 authors)
Journal of Cancer Research and Clinical Oncology
Published: Apr 2022
9 citations
9 citations
772 days before retraction
Quick Stats
Total Citations:
22
Years Since Retraction:
1.4 year
Open Access:
Yes
Last Checked:
Jul 24, 2025